Your browser doesn't support javascript.
loading
Beyond the Glycaemic Control of Dapagliflozin: Impact on Arterial Stiffness and Macroangiopathy.
González-Clemente, José M; García-Castillo, María; Gorgojo-Martínez, Juan J; Jiménez, Alberto; Llorente, Ignacio; Matute, Eduardo; Tejera, Cristina; Izarra, Aitziber; Lecube, Albert.
Afiliação
  • González-Clemente JM; Endocrinology and Nutrition Service, Parc Taulí University Hospital, Institute for Research and Innovation Parc Taulí, Universitat Autònoma de Barcelona, Sabadell, Barcelona, Spain.
  • García-Castillo M; Biomedical Research Networking Center in Diabetes and Associated Metabolic Disorders (CIBERDEM), Carlos III Health Institute, Madrid, Spain.
  • Gorgojo-Martínez JJ; Medical Department, AstraZeneca Spain, Madrid, Spain.
  • Jiménez A; Endocrinology and Nutrition Unit, Alcorcón Foundation University Hospital, Alcorcón, Madrid, Spain.
  • Llorente I; Medical Department, AstraZeneca Spain, Madrid, Spain.
  • Matute E; Endocrinology and Nutrition Service, Nuestra Señora de la Candelaria University Hospital, Canarias, Spain.
  • Tejera C; Medical Department, AstraZeneca Spain, Madrid, Spain.
  • Izarra A; Endocrinology and Nutrition Service, Ferrol University Hospital Complex, Ferrol, Spain.
  • Lecube A; Medical Department, AstraZeneca Spain, Madrid, Spain.
Diabetes Ther ; 13(7): 1281-1298, 2022 Jul.
Article em En | MEDLINE | ID: mdl-35687260

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article